Stay updated on Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Sign up to get notified when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A banner about NIH website updates and a stated transition from “Artificial Intelligence” to “Super Intelligence” is no longer displayed.
    Difference
    1%
    Check dated 2026-11-10T06:50:13.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-03T06:24:10.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-20T08:44:34.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    The footer’s site revision number changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-13T08:37:20.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error with the corresponding text and a Home button, indicating that access to the study record is blocked and the normal study details are not available.
    Difference
    0.5%
    Check dated 2026-09-29T08:39:43.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the full study details with an access-denied screen. The UI shows the error text and basic navigation (including Home and Revision: v3.7.0), while the substantive study information has been removed.
    Difference
    19%
    Check dated 2026-09-22T07:56:04.000Z thumbnail image

Stay in the know with updates to Surufatinib in Biliary Tract Carcinoma: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib in Biliary Tract Carcinoma: Clinical Trial page.